Product image of Irbepress (Irbesartan) supplied by GNH India

Irbepress

Active Ingredient:
Irbesartan
Origin:
EU

Irbepress (Irbesartan)

Irbesartan, the active ingredient in Irbepress, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It lowers elevated blood pressure and helps preserve kidney function in patients with diabetes‑related kidney disease, acting by blocking the effects of angiotensin II.

GNH India supplies Irbepress as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product complies with EU regulatory standards and is available for export to multiple regions, ensuring consistent quality and reliable supply chains for healthcare providers.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan is an angiotensin II receptor blocker used in cardiovascular and renal disease management.

  • Hypertension: reduces systolic and diastolic blood pressure to achieve target levels.
  • Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes.
  • Proteinuric kidney disease: decreases urinary protein excretion and protects renal function.

How It Works

  • Irbesartan selectively antagonizes angiotensin II type 1 (AT1) receptors on vascular smooth muscle, adrenal gland, and renal tubular cells. By blocking AT1 activation, it prevents vasoconstriction, aldosterone release, and sodium retention, leading to reduced peripheral resistance, lower blood pressure, and decreased intraglomerular pressure that helps preserve kidney function.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate pain in the head region.
  • Fatigue: feeling unusually tired or weak.
  • Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

  • Angioedema: swelling of the face, lips, tongue, or throat that may impair breathing.
  • Severe hypotension: markedly low blood pressure causing fainting or shock.
  • Acute renal failure: sudden loss of kidney function, indicated by rising creatinine levels.

Precautions & Warnings

Before initiating therapy, clinicians should consider several safety measures.

  • Blood pressure monitoring: ensure target levels are achieved without excessive drop.
  • Renal function assessment: check serum creatinine and eGFR periodically.
  • Serum potassium: monitor for hyperkalaemia, especially when combined with potassium‑sparing agents.
  • Hepatic impairment: use with caution in patients with liver disease.
  • Pregnancy: avoid use as safety in pregnancy is not established.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Aliskiren in diabetic patients: combined use can increase risk of renal impairment.
  • Dual blockade with ACE inhibitors or other ARBs: may cause excessive potassium rise and kidney injury.
  • Potassium‑sparing diuretics (e.g., spironolactone): heightens risk of hyperkalaemia.

Moderate Interactions (Monitor Closely)

  • Thiazide or loop diuretics: may enhance antihypertensive effect, requiring dose adjustment.
  • Lithium: increased lithium levels can lead to toxicity.
  • NSAIDs: may reduce antihypertensive efficacy and affect renal function.

Frequently Asked Questions

Irbepress contains irbesartan, an angiotensin II receptor blocker indicated for the treatment of hypertension and for slowing the progression of diabetic nephropathy. It helps lower blood pressure and protects kidney function in patients with type 2 diabetes.

Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptors on blood vessels, adrenal glands, and renal cells. This inhibition prevents vasoconstriction, aldosterone release, and sodium retention, resulting in reduced peripheral resistance, lower blood pressure, and decreased pressure within the kidneys.

The appropriate dose of Irbepress is individualized by the prescribing healthcare professional based on the patient’s blood pressure, kidney function, and overall clinical condition. Dosage adjustments are made according to response and tolerability.

Safety of irbesartan during pregnancy has not been established, and the drug is generally avoided in pregnant women because of potential fetal harm. Limited data exist for breastfeeding; therefore, use is usually discouraged unless the benefit outweighs the risk.

To order Irbepress, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Irbesartan belongs to the ARB class, offering blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with other ARBs, its efficacy and safety profile are comparable, while its renal‑protective effects are particularly valued in diabetic nephropathy.

Irbepress should be stored at room temperature, below 25 °C, in the original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiration date.

Irbepress is taken orally, usually as a whole tablet swallowed with a glass of water. It can be taken with or without food, and the dosing schedule (once daily) is determined by the prescriber.

Serious risks include angioedema (swelling of the face, lips, tongue, or throat), severe hypotension (dangerously low blood pressure), acute renal failure, and significant hyperkalaemia. Patients should seek immediate medical attention if they experience any of these symptoms.

Irbepress should be avoided in patients with known hypersensitivity to irbesartan or any ARB, in those with severe hepatic impairment, and in pregnant women. Caution is also advised for individuals with existing renal dysfunction or elevated serum potassium.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT